Cargando…
Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women
BACKGROUND: Soy consumption may protect against breast cancer through modification of estrogen metabolism. OBJECTIVE: We examined the effect of soy foods on urinary estrogens and the 2-hydroxy (OH)/16α-OH estrone (E(1)) ratio in 2 dietary interventions with premenopausal women. METHODS: BEAN1 was a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437012/ https://www.ncbi.nlm.nih.gov/pubmed/22713773 http://dx.doi.org/10.1038/ejcn.2012.71 |
_version_ | 1782242726282002432 |
---|---|
author | Maskarinec, Gertraud Morimoto, Yukiko Heak, Sreang Isaki, Marissa Steinbrecher, Astrid Custer, Laurie Franke, Adrian A. |
author_facet | Maskarinec, Gertraud Morimoto, Yukiko Heak, Sreang Isaki, Marissa Steinbrecher, Astrid Custer, Laurie Franke, Adrian A. |
author_sort | Maskarinec, Gertraud |
collection | PubMed |
description | BACKGROUND: Soy consumption may protect against breast cancer through modification of estrogen metabolism. OBJECTIVE: We examined the effect of soy foods on urinary estrogens and the 2-hydroxy (OH)/16α-OH estrone (E(1)) ratio in 2 dietary interventions with premenopausal women. METHODS: BEAN1 was a 2-year randomized trial and BEAN2 a 13-month randomized crossover study. In both interventions, study participants consumed a high-soy diet with 2 soy food servings/day and a low-soy diet with <3 servings of soy/week. Urine samples were collected at baseline and at the end of the diet periods, analyzed for 9 estrogen metabolites by liquid chromatography mass spectrometry, and adjusted for creatinine levels. For BEAN1, 2 samples for 188 participants and for BEAN2, 3 samples for 79 women were analyzed. We applied mixed-effects regression models with log-transformed values of estrogen metabolites and soy intake as the exposure variable. RESULTS: In BEAN1, no effect of the high-soy diet on individual estrogen metabolites or hydroxylation pathways was observed. The median 2-OH/16α-OH E(1) ratio decreased non-significantly in the intervention group from 6.2 to 5.2 as compared to 6.8 and 7.2 in the control group (p=0.63). In BEAN2, only 4-OHE(1) was significantly lower after the high-soy diet. Interaction terms of the high-soy diet with equol producer status, ethnicity, and weight status revealed no significant effect modification. CONCLUSIONS: Contrary to our hypothesis and some previous reports, the results from 2 well controlled dietary interventions do not support an effect of a high-soy diet on a panel of urinary estrogen metabolites and the 2-OH/16α-OHE(1) ratio. |
format | Online Article Text |
id | pubmed-3437012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
record_format | MEDLINE/PubMed |
spelling | pubmed-34370122013-03-01 Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women Maskarinec, Gertraud Morimoto, Yukiko Heak, Sreang Isaki, Marissa Steinbrecher, Astrid Custer, Laurie Franke, Adrian A. Eur J Clin Nutr Article BACKGROUND: Soy consumption may protect against breast cancer through modification of estrogen metabolism. OBJECTIVE: We examined the effect of soy foods on urinary estrogens and the 2-hydroxy (OH)/16α-OH estrone (E(1)) ratio in 2 dietary interventions with premenopausal women. METHODS: BEAN1 was a 2-year randomized trial and BEAN2 a 13-month randomized crossover study. In both interventions, study participants consumed a high-soy diet with 2 soy food servings/day and a low-soy diet with <3 servings of soy/week. Urine samples were collected at baseline and at the end of the diet periods, analyzed for 9 estrogen metabolites by liquid chromatography mass spectrometry, and adjusted for creatinine levels. For BEAN1, 2 samples for 188 participants and for BEAN2, 3 samples for 79 women were analyzed. We applied mixed-effects regression models with log-transformed values of estrogen metabolites and soy intake as the exposure variable. RESULTS: In BEAN1, no effect of the high-soy diet on individual estrogen metabolites or hydroxylation pathways was observed. The median 2-OH/16α-OH E(1) ratio decreased non-significantly in the intervention group from 6.2 to 5.2 as compared to 6.8 and 7.2 in the control group (p=0.63). In BEAN2, only 4-OHE(1) was significantly lower after the high-soy diet. Interaction terms of the high-soy diet with equol producer status, ethnicity, and weight status revealed no significant effect modification. CONCLUSIONS: Contrary to our hypothesis and some previous reports, the results from 2 well controlled dietary interventions do not support an effect of a high-soy diet on a panel of urinary estrogen metabolites and the 2-OH/16α-OHE(1) ratio. 2012-06-20 2012-09 /pmc/articles/PMC3437012/ /pubmed/22713773 http://dx.doi.org/10.1038/ejcn.2012.71 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Maskarinec, Gertraud Morimoto, Yukiko Heak, Sreang Isaki, Marissa Steinbrecher, Astrid Custer, Laurie Franke, Adrian A. Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title | Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title_full | Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title_fullStr | Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title_full_unstemmed | Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title_short | Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women |
title_sort | urinary estrogen metabolites in 2 soy trials with premenopausal women |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437012/ https://www.ncbi.nlm.nih.gov/pubmed/22713773 http://dx.doi.org/10.1038/ejcn.2012.71 |
work_keys_str_mv | AT maskarinecgertraud urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT morimotoyukiko urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT heaksreang urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT isakimarissa urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT steinbrecherastrid urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT custerlaurie urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen AT frankeadriana urinaryestrogenmetabolitesin2soytrialswithpremenopausalwomen |